Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 4

Markus Reinthaler, Sunil K. Aggarwal, Rodney De Palma, Ulf Landmesser 1, Georg Froehlich,Predictors of clinical outcome in transfemoral TAVI: Circumferential iliofemoral calcifications and manufacturer-derived recommendations

Pages
297–305
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Circumferential iliofemoral calcifica- tions may provide independent prognostic information in patients undergoing TAVI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to investigate the predictive value of circumferential iliofemoral calcifications and current manufacturer recom- mendations, which are not evidence-based, in transfemoral (TF) transcatheter aortic valve implantation (TAVI) Methods: A patient cohort with a broad range of iliofemoral anatomies undergoing TF TAVI (n=132) were retrospectively divided as suitable (n=76, 58%) and unsuitable (n=56, 42%) candidates according to current recommendations.
📊
Key Findings & Data:Results: Vessel properties were significantly worse in the unsuitable group.
💡
Conclusion & Impact:Circumferential iliofemoral calcifica- tions may provide independent prognostic information in patients undergoing TAVI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to investigate the predictive value of circumferential iliofemoral calcifications and current manufacturer recom- mendations, which are not evidence-based, in transfemoral (TF) transcatheter aortic valve implantation (TAVI) Methods: A patient cohort with a broad range of iliofemoral anatomies undergoing TF TAVI (n=132) were retrospectively divided as suitable (n=76, 58%) and unsuitable (n=56, 42%) candidates according to current recommendations. Iliofemoral angiography and reconstructed mul- tislice CT (MSCT) images were used for access screening in the majority of patients. Results: Vessel properties were significantly worse in the unsuitable group. The sheath-to-iliofemoral artery ratio (SIFAR) and calcium score were 1.35±0.2 and 1.7±0.8 in the unsuitable group, compared to 1.0±0.12 (p<0.0001) and 1.0±0.7 (p=0.0001) in the suitable patients. Major vas- cular complications (MVCs) occurred more frequently in the unsuitable group (10.7% vs. 2.6%, p=0.07) and were predicted by SIFAR [OR: 64, 95% CI: 1.4-2971, p=0.03] and circumferential iliofemoral calcifications [OR: 6, 95% CI: 1.2-26, p=0.025]. In the multivariate analysis, circumferen- tial calcifications [HR: 3.6, 95% CI: 1-13.2, p=0.043] but not major vascular complications (MVCs) or manufacturer recommendations were associated with increased mortality. Conclusion: According to our results, manufacturer recommendations are safe but overly conservative. Circumferential iliofemoral calcifica- tions may provide independent prognostic information in patients undergoing TAVI.

🔖

Cite This Article

REİNTHALER, M., AGGARWAL, S. K., PALMA, R. D., LANDMESSER, U., FROEHLİCH, G., YAP, J., MEIER, P., MULLEN, M. J. (2015). Markus Reinthaler, Sunil K. Aggarwal, Rodney De Palma, Ulf Landmesser 1, Georg Froehlich,Predictors of clinical outcome in transfemoral TAVI: Circumferential iliofemoral calcifications and manufacturer-derived recommendations. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 4, 297–305. https://ajindex.com/articles/363509

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010: 363: 1597- 607. [CrossRef] 2. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aor- tic valve replacement. J Am Coll Cardiol 2009
  2. [CrossRef] 3. Mussardo M, Latib A, Chieffo A, Godino C, Ielasi A, Cioni M, et al. Periprocedural and short-term outcomes of transfemoral trans- catheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC Cardiovasc Interv 2011
  3. [CrossRef] 4. Piazza N, Lange R, Martucci G, Serruys PW. Patient selection for transcatheter aortic valve implantation: patient risk profile and anatomical selection criteria. Arch Cardiovasc Dis 2012
  4. [CrossRef] 5. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. Acute and late outcomes of the multi- center Canadian experience. J Am Coll Cardiol 2010
  5. [CrossRef] 6. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. The UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol 2011
  6. [CrossRef] 7. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006
  7. [CrossRef] 8. Généreux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, et al. PARTNER trial investigators. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTicTraNscathetER Valve) trial. J Am Coll Cardiol 2012
  8. [CrossRef] 9. Tchetche D, Van der Boon RM, Dumonteil N, Chieffo A, Van Mieghem NM, Farah B, et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. Am Heart J 2012
  9. [CrossRef] 10. Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, et a